title: Inflammation of actinic keratoses and acral erythrodysesthesia during capecitabine treatment.
authors.forename: Laura
authors.initials: L
authors.lastname: Peramiquel
authors.forename: Joan
authors.initials: J
authors.lastname: Dalmau
authors.forename: Luís
authors.initials: L
authors.lastname: Puig
authors.forename: Esther
authors.initials: E
authors.lastname: Roé
authors.forename: M Teresa
authors.initials: MT
authors.lastname: Fernández-Figueras
authors.forename: Agustín
authors.initials: A
authors.lastname: Alomar
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects* / Q000627:therapeutic use; D000069287:Capecitabine; D003110:Colonic Neoplasms / Q000188:drug therapy; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004890:Erythema / Q000139:chemically induced; D005472:Fluorouracil / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D007642:Keratosis / Q000139:chemically induced*; D008297:Male; D010292:Paresthesia / Q000139:chemically induced*
chemical_list: D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil